Skip to content

Advertisement

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review

BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:722

https://doi.org/10.1186/s12879-017-2820-z

Received: 24 May 2017

Accepted: 6 November 2017

Published: 16 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 May 2017 Submitted Original manuscript
13 Jul 2017 Reviewed Reviewer Report - Etienne Brochot
25 Aug 2017 Reviewed Reviewer Report - Mauro Zaccarelli
5 Oct 2017 Author responded Author comments - Hosnieh Fathi
Resubmission - Version 2
5 Oct 2017 Submitted Manuscript version 2
27 Oct 2017 Author responded Author comments - Hosnieh Fathi
Resubmission - Version 3
27 Oct 2017 Submitted Manuscript version 3
Publishing
6 Nov 2017 Editorially accepted
16 Nov 2017 Article published 10.1186/s12879-017-2820-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Almirall Ltd, London, UK
(2)
Bristol-Myers Squibb Pharmaceuticals Ltd, London, UK
(3)
UCL Medical School, Kings College Hospital, London, UK

Advertisement